Mount Yale Investment Advisors, LLC Avadel Pharmaceuticals PLC Call Options Transaction History
Mount Yale Investment Advisors, LLC
- $1.11 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AVDL
# of Institutions
6Shares Held
738KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL600KShares$5.3 Million3.14% of portfolio
-
Schulhoff & CO Inc138KShares$1.22 Million0.52% of portfolio
-
American Portfolios Advisors Holbrook, NY500Shares$4,4200.0% of portfolio
-
American Research & Management Co.100Shares$8840.0% of portfolio
-
Exane Derivatives33Shares$2910.0% of portfolio
About AVADEL PHARMACEUTICALS PLC
- Ticker AVDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 60,581,300
- Market Cap $536M
- Description
- Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...